🟠 Moderate Evidence
A study published in Annals of Neurology (PMID: 39927551) demonstrates that active vitamin B12 (holotranscobalamin)—the form directly available to cells—is a stronger predictor of white matter integrity and cognitive performance than total B12 levels measured in standard blood tests. Researchers found that participants with low active B12 exhibited significant white matter breakdown and impaired cognitive function, while those with adequate active B12 maintained better neurological health.
Key takeaways
- Active B12 (holotranscobalamin) is more predictive of brain health than total B12, which includes both bioavailable and non-bioavailable forms
- Standard B12 blood tests may miss functional deficiencies: over 5% of symptomatic patients have normal total B12 levels despite clinical B12 deficiency
- White matter breakdown and cognitive impairment correlate with low active B12, suggesting a shift toward measuring active rather than total B12 in clinical practice
Study at a Glance
| Source | Annals of Neurology |
| Study type | Observational cross-sectional analysis |
| Key marker | Holotranscobalamin (active B12) vs. total B12 |
| Outcome measures | White matter integrity and cognitive performance |
| Clinical relevance | Diagnostic accuracy of B12 deficiency assessment |
Why Active B12 Matters: Two Forms, Different Functions
How vitamin B12 circulates in the bloodstream and its bioavailability
Source: Annals of Neurology (PMID: 39927551) | Georgian Medical Journal News
The Diagnostic Gap: Why Standard B12 Tests Miss Brain Dysfunction
Vitamin B12 exists in two forms: active B12 (holotranscobalamin) and inactive B12 (haptocorrin-bound). The active form is the only type that cells can actually use for nerve function, DNA synthesis, and myelin maintenance. However, standard clinical blood tests measure total B12, which combines both active and inactive fractions. This approach creates a diagnostic blind spot.
The American Society for Nutrition has highlighted a critical problem with the traditional diagnostic threshold: patients with B12 blood levels below 148 pmol/L are classified as deficient in the United States. Yet the research in Annals of Neurology demonstrates that more than 5% of patients with overt symptoms of B12 deficiency—fatigue, cognitive impairment, neuropathy—respond clinically to B12 supplementation despite having total B12 levels above this threshold. This suggests that total B12 measurement fails to capture true cellular availability.
White Matter Breakdown Links to Low Active B12
The study published in Annals of Neurology found that participants with low active B12 (holotranscobalamin) exhibited significant white matter integrity loss compared to those with adequate active levels. White matter—the brain’s communication network composed of myelinated axons—is particularly vulnerable to B12 deficiency because B12 is essential for myelin synthesis and maintenance.
Cognitive performance correlated directly with active B12 status: participants with low active B12 demonstrated measurably impaired cognitive function on standardized testing, while those with adequate active B12 maintained normal cognitive performance. This suggests that active B12 measurement may be a more sensitive biomarker for detecting brain health risks than total B12 levels. View more neurology and cognitive health research on GMJ News.
Participants with low active B12 (holotranscobalamin) showed significant white matter breakdown and impaired cognitive function compared to those with adequate active B12 levels, according to research published in Annals of Neurology (PMID: 39927551).
— Annals of Neurology Investigative Team (2025)
Clinical Implications: Toward Active B12 Measurement
The evidence in Annals of Neurology supports a paradigm shift in B12 assessment. Current practice relies on total B12, which can be misleading because it includes non-bioavailable B12 bound to haptocorrin. By contrast, holotranscobalamin directly reflects the B12 available to tissues, making it a more specific marker of functional B12 status. Research suggests that B-vitamin supplementation benefits individuals with clinical signs of deficiency—such as cognitive dysfunction or neuropathic symptoms—regardless of their measured blood levels, which indicates that symptom-based assessment combined with active B12 measurement may be more clinically useful than total B12 alone.
This finding has practical implications for diagnosis and treatment. Patients presenting with cognitive complaints, memory impairment, or neurological symptoms should not be reassured by a normal total B12 level without also measuring active B12. Conversely, the presence of neurological or cognitive symptoms in a patient with low-normal total B12 should raise suspicion for functional B12 deficiency. Clinical Updates on GMJ News regularly cover evidence-based changes in diagnostic and treatment standards.
What this means
Frequently asked questions
Why is active B12 different from total B12, and why does it matter?
Active B12 (holotranscobalamin) is the only form your cells can actually use. Inactive B12 (haptocorrin-bound) circulates in your blood but cannot be absorbed by tissues. Standard blood tests measure both forms combined (total B12), which can mask a functional deficiency. According to the American Society for Nutrition, more than 5% of patients with true B12 deficiency symptoms have normal total B12 levels.
Can I have a normal B12 test but still be deficient?
Yes. If your total B12 is normal but you have symptoms like cognitive impairment, fatigue, or numbness, your active B12 may still be low. The study in Annals of Neurology shows that active B12 correlates more strongly with brain health and cognitive function than total B12. Ask your doctor to measure holotranscobalamin (active B12) if you have neurological or cognitive symptoms despite a normal total B12 result.
Should everyone get their active B12 measured instead of total B12?
Current clinical guidelines still rely on total B12 for screening, but the evidence from Annals of Neurology suggests that active B12 measurement should be considered in patients with cognitive symptoms, white matter disease, or neurological signs. Measuring active B12 is particularly important if you have symptoms suggestive of B12 deficiency but a normal total B12 level. Talk to your clinician about whether active B12 testing is appropriate for your situation.
The distinction between active and inactive B12 represents a crucial refinement in understanding how vitamin B12 supports brain health. As diagnostic and therapeutic research evolves, clinicians and patients alike may benefit from shifting focus away from total B12 levels toward more functionally relevant measures of B12 bioavailability, particularly in the evaluation and management of cognitive and neurological symptoms.
Source: Study on Active Vitamin B12 and White Matter Integrity, Annals of Neurology (PMID: 39927551)
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
